1	Overproduction	overproduction	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	NFKB2	nfkb2	_	_	_	_	_	_	_
4	(	(	_	_	_	_	_	_	_
5	lyt-10	lyt-10	_	_	_	_	_	_	_
6	)	)	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	c-Rel	c-rel	_	_	_	_	_	_	_
9	:	:	_	_	_	_	_	_	_
10	a	a	_	_	_	_	_	_	_
11	mechanism	mechanism	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	HTLV-I	HTLV-I	_	_	_	_	_	_	_
14	Tax-mediated	tax-mediated	_	_	_	_	_	_	_
15	trans-activation	trans-activation	_	_	_	_	_	_	_
16	via	via	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	NF-kappa	NF-kappa	_	_	_	_	_	_	_
19	B	B	_	_	_	_	_	_	_
20	signalling	signalling	_	_	_	_	_	_	_
21	pathway	pathway	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Molecular	molecular	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	biochemical	biochemical	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	epidemiological	epidemiological	_	_	_	_	_	_	_
6	evidence	evidence	_	_	_	_	_	_	_
7	implicate	implicate	_	_	_	_	_	_	_
8	HTLV-I	HTLV-I	_	_	_	_	_	_	_
9	as	as	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	etiologic	etiologic	_	_	_	_	_	_	_
12	agent	agent	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	adult	adult	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cell	cell	_	_	_	_	_	_	_
17	leukemia	leukemia	_	_	_	_	_	_	_
18	(	(	_	_	_	_	_	_	_
19	ATL	ATL	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	Tax	Tax	_	_	_	_	_	_	_
3	protein	protein	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	HTLV-I	HTLV-I	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	positive	positive	_	_	_	_	_	_	_
9	transcriptional	transcriptional	_	_	_	_	_	_	_
10	activator	activator	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	HTLV-I	HTLV-I	_	_	_	_	_	_	_
13	gene	gene	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	viral	viral	_	_	_	_	_	_	_
19	oncogene	oncogene	_	_	_	_	_	_	_
20	that	that	_	_	_	_	_	_	_
21	also	also	_	_	_	_	_	_	_
22	increases	increase	_	_	_	_	_	_	_
23	transcription	transcription	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	cellular	cellular	_	_	_	_	_	_	_
26	genes	gene	_	_	_	_	_	_	_
27	including	include	_	_	_	_	_	_	_
28	GM-CSF	GM-CSF	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	IL-2R	IL-2R	_	_	_	_	_	_	_
31	alpha	alpha	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	IL-2	il-2	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	One	one	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	cellular	cellular	_	_	_	_	_	_	_
5	targets	target	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	trans-activating	trans-activating	_	_	_	_	_	_	_
9	effects	effect	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	Tax	Tax	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	NF-kappa	NF-kappa	_	_	_	_	_	_	_
15	B/Rel	B/Rel	_	_	_	_	_	_	_
16	family	family	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	transcription	transcription	_	_	_	_	_	_	_
19	factors	factor	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	pleiotropic	pleiotropic	_	_	_	_	_	_	_
22	regulators	regulator	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	immunoregulatory	immunoregulatory	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	cytokine	cytokine	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	viral	viral	_	_	_	_	_	_	_
29	gene	gene	_	_	_	_	_	_	_
30	expression	expression	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	demonstrate	demonstrate	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	NFKB2	nfkb2	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	lyt-10	lyt-10	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	c-Rel	c-rel	_	_	_	_	_	_	_
14	are	be	_	_	_	_	_	_	_
15	overexpressed	overexpresse	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	HTLV-I	HTLV-I	_	_	_	_	_	_	_
18	infected	infected	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	Tax-expressing	tax-expressing	_	_	_	_	_	_	_
21	cells	cell	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	,	,	_	_	_	_	_	_	_
24	together	together	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	account	account	_	_	_	_	_	_	_
27	for	for	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	majority	majority	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	constitutive	constitutive	_	_	_	_	_	_	_
33	NF-kappa	NF-kappa	_	_	_	_	_	_	_
34	B	B	_	_	_	_	_	_	_
35	binding	binding	_	_	_	_	_	_	_
36	activity	activity	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	these	these	_	_	_	_	_	_	_
39	cells	cell	_	_	_	_	_	_	_
40	before	before	_	_	_	_	_	_	_
41	and	and	_	_	_	_	_	_	_
42	after	after	_	_	_	_	_	_	_
43	PMA	PMA	_	_	_	_	_	_	_
44	stimulation	stimulation	_	_	_	_	_	_	_
45	.	.	_	_	_	_	_	_	_

1	Most	most	_	_	_	_	_	_	_
2	importantly	importantly	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	we	we	_	_	_	_	_	_	_
5	show	show	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	Tax-dependent	tax-dependent	_	_	_	_	_	_	_
8	correlation	correlation	_	_	_	_	_	_	_
9	between	between	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	NFKB2(p100)	nfkb2(p100)	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	processing	processing	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	DNA	dna	_	_	_	_	_	_	_
18	binding	binding	_	_	_	_	_	_	_
19	NFKB2(p52)	nfkb2(p52)	_	_	_	_	_	_	_
20	form	form	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	induction	induction	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	c-Rel	c-rel	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	and	and	_	_	_	_	_	_	_
27	trans-activation	trans-activation	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	NF-kappa	NF-kappa	_	_	_	_	_	_	_
30	B-mediated	b-mediated	_	_	_	_	_	_	_
31	gene	gene	_	_	_	_	_	_	_
32	expression	expression	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	NFKB2	nfkb2	_	_	_	_	_	_	_
5	precursor	precursor	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	physically	physically	_	_	_	_	_	_	_
8	associated	associate	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	c-Rel	c-rel	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	Tax	Tax	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	HTLV-I	HTLV-I	_	_	_	_	_	_	_
16	infected	infected	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	propose	propose	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	NFKB2	nfkb2	_	_	_	_	_	_	_
5	synthesis	synthesis	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	processing	processing	_	_	_	_	_	_	_
8	allows	allow	_	_	_	_	_	_	_
9	continuous	continuous	_	_	_	_	_	_	_
10	nuclear	nuclear	_	_	_	_	_	_	_
11	expression	expression	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	an	an	_	_	_	_	_	_	_
14	otherwise	otherwise	_	_	_	_	_	_	_
15	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
16	protein	protein	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	conjunction	conjunction	_	_	_	_	_	_	_
21	with	with	_	_	_	_	_	_	_
22	overexpression	overexpression	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	c-Rel	c-rel	_	_	_	_	_	_	_
25	,	,	_	_	_	_	_	_	_
26	NFKB2	nfkb2	_	_	_	_	_	_	_
27	alters	alter	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	NF-kappa	NF-kappa	_	_	_	_	_	_	_
30	B	B	_	_	_	_	_	_	_
31	signalling	signalling	_	_	_	_	_	_	_
32	pathway	pathway	_	_	_	_	_	_	_
33	and	and	_	_	_	_	_	_	_
34	contributes	contribute	_	_	_	_	_	_	_
35	to	to	_	_	_	_	_	_	_
36	leukemic	leukemic	_	_	_	_	_	_	_
37	transformation	transformation	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	T	t	_	_	_	_	_	_	_
40	cells	cell	_	_	_	_	_	_	_
41	by	by	_	_	_	_	_	_	_
42	HTLV-I	HTLV-I	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

